Coffea canephora (Robusta)

Coffea canephora (robusta coffee) provides antioxidant protection through chlorogenic acids, containing 342.8-1079.4 mg per 100g. Its caffeine content offers antibacterial properties by disrupting bacterial cell wall synthesis.

Origin & History

Coffea canephora (Robusta) is a species of coffee plant native to central and western sub-Saharan Africa, cultivated as a major commercial coffee cultivar alongside Coffea arabica. The bioactive compounds are extracted from seeds (beans), flowers, husks, and leaves using methanolic or hot water infusion methods.

Historical & Cultural Context

No historical context or traditional medicine uses for Coffea canephora were documented in the research sources. Modern applications focus on its bioactive compounds for potential antibacterial and antioxidant benefits.

Health Benefits

• Antioxidant activity from chlorogenic acids (CGA) content ranging from 342.8–1079.4 mg/100 g (preliminary evidence from phytochemical analysis only)
• Antibacterial properties through caffeine's inhibition of bacterial cell wall synthesis (in vitro evidence only)
• Anti-inflammatory potential from phenolic compounds including caffeic acid and ferulic acid (mechanistic inference, no clinical data)
• Potential anti-carcinogenic properties from CGA content (theoretical based on constituent properties)
• Rich source of bioactive alkaloids including caffeine (515.6–745.9 mg/100 g) and trigonelline (453.8–645.2 mg/100 g) (composition data only, no clinical outcomes)

How It Works

Chlorogenic acids in Coffea canephora act as phenolic antioxidants by scavenging reactive oxygen species and chelating metal ions. Caffeine inhibits bacterial growth by interfering with peptidoglycan synthesis in bacterial cell walls. The anti-inflammatory potential likely involves inhibition of cyclooxygenase and lipoxygenase pathways.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were found in the research dossier. Available evidence consists solely of phytochemical composition studies and in vitro antibacterial activity assessments without human data or PubMed PMIDs.

Clinical Summary

Current evidence for Coffea canephora benefits relies primarily on phytochemical analyses and in vitro studies. Chlorogenic acid content has been quantified through laboratory analysis showing significant variation between samples. Antibacterial activity has been demonstrated in laboratory conditions against various bacterial strains. Human clinical trials specifically examining robusta coffee extracts are limited, making therapeutic applications preliminary.

Nutritional Profile

Robusta coffee beans contain a distinct nutritional and phytochemical profile compared to Arabica. Macronutrients per 100g green bean: protein 10–11.5g (higher than Arabica, rich in glutamic acid, aspartic acid, and leucine), lipids 7–10g (lower fat than Arabica; lipid fraction includes diterpenes cafestol and kahweol at lower concentrations than Arabica, ~0.1–0.5mg/g), carbohydrates 38–42g (predominantly sucrose 3–7g/100g pre-roast, degraded significantly upon roasting; polysaccharides including galactomannans and arabinogalactans 40–55% of dry weight). Caffeine content is notably elevated at 2.0–2.7g/100g green bean (approximately double that of Arabica at 1.2–1.5g/100g), directly contributing to its stronger stimulant profile. Chlorogenic acids (CGAs) are the dominant bioactive compounds, present at 342.8–1079.4mg/100g, with 5-caffeoylquinolinic acid (5-CQA) as the primary isomer; Robusta consistently shows higher CGA concentrations than Arabica (7–12% vs 5.5–8% dry weight basis). Phenolic acids include caffeic acid (~50–150mg/100g green bean), ferulic acid (~10–40mg/100g), and p-coumaric acid (trace levels). Trigonelline content: 0.6–0.9g/100g (lower than Arabica's 1.0–1.2g/100g), which degrades to niacin (vitamin B3) during roasting, yielding approximately 10–40mg niacin/100g roasted coffee depending on roast degree. Minerals per 100g roasted ground coffee: potassium 1,600–2,000mg (high bioavailability in brewed form ~70–80% extraction), magnesium 50–80mg, phosphorus 140–170mg, manganese 0.5–1.2mg, copper 0.1–0.3mg. B vitamins: niacin (B3) 10–40mg/100g roasted (roast-dependent), riboflavin (B2) ~0.2mg/100g. Melanoidins (Maillard reaction products) constitute 25–30% of roasted bean dry weight and contribute antioxidant and prebiotic properties. CGA bioavailability from brewed Robusta is estimated at 33–55% absorption in the small intestine; remaining CGAs are metabolized by colonic microbiota into hydroxycinnamic acids. Caffeine bioavailability approaches ~99% upon oral ingestion. Lipid-bound diterpenes (cafestol/kahweol) have low extraction in filtered coffee (<0.2mg/cup) but higher in unfiltered preparations (1–5mg/cup); relevant for cholesterol-modulating effects at higher intake levels.

Preparation & Dosage

No clinically studied dosage ranges are available. Phytochemical analysis shows methanolic flower extracts contain caffeine (515.6–745.9 mg/100 g), trigonelline (453.8–645.2 mg/100 g), and total CGA (342.8–1079.4 mg/100 g). Hot water infusions extract 84% CGA and 91% caffeine. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, Rhodiola rosea, Panax ginseng, Cordyceps

Safety & Interactions

Caffeine content in Coffea canephora can cause jitteriness, insomnia, and increased heart rate in sensitive individuals. May interact with medications metabolized by CYP1A2 enzyme, including theophylline and certain antidepressants. Contraindicated in individuals with severe anxiety disorders or cardiac arrhythmias. Pregnant women should limit caffeine intake to under 200mg daily from all sources.